Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia

被引：0
|
作者：
Snedecor, S. J. [1 ]
Botteman, M. F. [1 ]
Schaefer, K. [2 ]
Barry, N. [2 ]
Pickard, A. [3 ]
机构：
[1] Pharmerit N Amer LLC, Bethesda, MD USA
[2] Sepracor Inc, Marlborough, MA USA
[3] Univ Illinois, Ctr Pharmacoecon Res, Chicago, IL USA
来源：
SLEEP | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
750
引用
收藏
页码：A246 / A246
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Eszopiclone for the Treatment of Adults with Primary Chronic Insomnia
    Snedecor, Sonya J.
    Botteman, Marc F.
    Bojke, Chris
    Schaefer, Kendyl
    Barry, Nadine
    Pickard, A. Simon
    [J]. SLEEP, 2009, 32 (06) : 817 - 824
  • [2] Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia in the US
    Bell, C.
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Pickard, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 305 - 305
  • [3] Cost-effectiveness of longer-term treatment with eszopiclone 3mg in adults with primary insomnia
    Botteman, M
    Ozminkowski, R
    Wang, S
    Pashos, CL
    Foley, DJ
    Schaefer, K
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 323 - 323
  • [4] An analytical model to predict the cost-effectiveness of long-term eszopiclone for the treatment of primary insomnia
    Snedecor, S. L.
    Botteman, M. F.
    Schaefer, K.
    Barry, N.
    Rubens, R.
    Pickard, A. S.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A381 - A382
  • [5] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults - A decision analytical model
    Botteman, Marc F.
    Ozminkowski, Ron J.
    Wang, Shaohung
    Pashos, Chris L.
    Schaefer, Kendyl
    Foley, Daniel J.
    [J]. CNS DRUGS, 2007, 21 (04) : 319 - 334
  • [6] TREATMENT WITH ESZOPICLONE IN ADULTS WITH PRIMARY INSOMNIA: PREDICTORS OF RESPONSE
    Marshall, R. D.
    Grinnell, T.
    Zummo, J.
    Schweizer, E.
    [J]. SLEEP, 2011, 34 : A177 - A177
  • [7] Cost Effectiveness of Long-Term Treatment with Eszopiclone for Primary Insomnia in AdultsA Decision Analytical Model
    Marc F. Botteman
    Ron J. Ozminkowski
    Shaohung Wang
    Chris L. Pashos
    Kendyl Schaefer
    Daniel J. Foley
    [J]. CNS Drugs, 2007, 21 : 319 - 334
  • [8] Comparison of four preference-based SF-36/SF-12 algorithms to evaluate the cost-effectiveness of treatment for primary insomnia with eszopiclone
    Snedecor, S. L.
    Botteman, M. F.
    Schaefer, K.
    Barry, I. N.
    Rubens, R.
    Pickard, A. S.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A389 - A389
  • [9] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: A decision analytical model. (vol 21, pg 319, 2007)
    Botteman, M. F.
    Ozminkowski, R. J.
    Wang, S.
    Pashos, C. L.
    Schaefer, K.
    Foley, D. J.
    [J]. CNS DRUGS, 2007, 21 (05) : 405 - 405
  • [10] Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia
    Martin, SA
    Aikens, JE
    Chervin, RD
    [J]. SLEEP MEDICINE REVIEWS, 2004, 8 (01) : 63 - 72
12345